Accuracy of procalcitonin for outcome prediction in unselected postoperative critically ill patients

Shock

Volumn 31, Issue 6, 2009, Pages 568-573

  Schneider, Christian P ^a   Yilmaz, Yeshim ^a   Kleespies, Axel ^a   Jauch, Karl Walter ^a   Hartl, Wolfgang H ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Complications; Hospital length of stay; Mortality; Operation; Procalcitonin

Indexed keywords

BIOCHEMICAL MARKER; INTERLEUKIN 6; PROCALCITONIN;

ACUTE PHYSIOLOGY AND CHRONIC HEALTH EVALUATION II SCORE; ADULT; AGED; ARTICLE; BIOCHEMISTRY; CRITICALLY ILL PATIENT; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; FEMALE; HEART SURGERY; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIPLE TRAUMA; OUTCOME ASSESSMENT; PERITONITIS; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEPSIS; SURGICAL MORTALITY;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; CALCITONIN; CRITICAL ILLNESS; FEMALE; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; MODELS, STATISTICAL; POSTOPERATIVE PERIOD; PROTEIN PRECURSORS; RETROSPECTIVE STUDIES;

EID: 68049085313     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e318193cb52     Document Type: Article

References (33)

1. Schneider HG, Lam QT: Procalcitonin for the clinical laboratory: a review. Pathology 39(4):383-390, 2007.
2. Whicher J, Bienvenu J, Monneret G: Procalcitonin as an acute phase marker. Ann Clin Biochem 38(Pt 5):483-493, 2001.
3. Tang BM, Eslick GD, Craig JC, McLean AS: Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 7(3):210-217, 2007.
4. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY: Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 34(7):1996-2003, 2006.
5. Sponholz C, Sakr Y, Reinhart K, Brunkhorst F: Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature. Crit Care 10(5):R145, 2006.
6. Ten Boekel E, Vroonhof K, Huisman A, van Kampen C, de Kieviet W: Clinical laboratory findings associated with in-hospital mortality. Clin Chim Acta 372(1-2):1-13, 2006.
7. Wanner GA, Keel M, Steckholzer U, Beier W, Stocker R, Ertel W: Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med 28(4): 950-957, 2000.
8. Hensler T, Sauerland S, Lefering R, Nagelschmidt M, Bouillon B, Andermahr J, Neugebauer EA: The clinical value of procalcitonin and neopterin in predicting sepsis and organ failure after major trauma. Shock 20(5): 420-426, 2003.
9. Fritz HG, Brandes H, Bredle DL, Bitterlich A, Vollandt R, Specht M, Franke UF, Wahlers T, Meier-Hellmann A: Post-operative hypoalbuminaemia and procalcitonin elevation for prediction of outcome in cardiopulmonary bypass surgery. Acta Anaesthesiol Scand 47(10):1276-1283, 2003.
10. Szakmany T, Molnar Z: Procalcitonin levels do not predict mortality following major abdominal surgery. Can J Anaesth 50(10):1082-1083, 2003.
11. Wunder C, Eichelbrönner O, Roewer N: Are IL-6, IL-10 and PCT plasma concentrations reliable for outcome prediction in severe sepsis? A comparison with APACHE III and SAPS II. Inflamm Res 53(4):158-163, 2004.
12. Novotny A, Emmanuel K, Matevossian E, Kriner M, Ulm K, Bartels H, Holzmann B, Weighardt H, Siewert JR: Use of procalcitonin for early prediction of lethal outcome of postoperative sepsis. Am J Surg 194(1): 35-39, 2007.
13. Hosmer DW, Lemeshow S: Applied Survival Analysis. New York: Wiley; 1999:158
14. Klein JP, Moeschberger ML. Survival Analysis. Techniques for Censored and Truncated Data. New York: Springer; 2003:295.
15. Hosmer DW, Lemeshow S: Applied Logistic Regression. New York: Wiley; 1989:84.
16. Fogarty J, Baker RS, Hudson SE: Case studies in the use of ROC curve analysis for sensor-based estimates in human computer interaction. Graphics Interface 129-136, 2005.
17. Akobeng AK: Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr 96(5):644-647, 2007.
18. Schuetz P, Christ-Crain M, Müller B: Biomarkers to improve diagnostic and prognostic accuracy in systemic infections. Curr Opin Crit Care 13(5): 578-585, 2007.
19. Oberholzer A, Souza SM, Tschoeke SK, Oberholzer C, Abouhamze A, Pribble JP, Moldawer LL: Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis. Shock 23(6): 488-493, 2005.
20. Pettilä V, Hynninen M, Takkunen O, Kuusela P, Valtonen M: Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis. Intensive Care Med 28(9):1220-1225, 2002.
21. Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, Vadas L, Pugin J; Geneva Sepsis Network. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 164(3):396-402, 2001.
22. Jensen JU, Heslet L, Jensen TH, Espersen K, Steffensen P, Tvede M: Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 34(10):2596-2602, 2006.
23. Christ-Crain M, Morgenthaler NG, Stolz D, Müller C, Bingisser R, Harbarth S, Tamm M, Struck J, Bergmann A, Müller B: Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]. Crit Care 10(3):R96, 2006.
24. Fraunberger P, Wang Y, Holler E, Parhofer KG, Nagel D, Walli AK, Seidel D: Prognostic value of interleukin 6, procalcitonin, and C-reactive protein levels in intensive care unit patients during first increase of fever. Shock 26(1):10-12, 2006.
25. Schuetz P, Christ-Crain M, Morgenthaler NG, Struck J, Bergmann A, Müller B: Circulating precursor levels of endothelin-1 and adrenomedullin, two endothelium-derived, counteracting substances, in sepsis. Endothelium 14(6): 345-351, 2007.
26. Dörge H, Schöndube FA, Dörge P, Seipelt R, Voss M, Messmer BJ: Procalcitonin is a valuable prognostic marker in cardiac surgery but not specific for infection. Thorac Cardiovasc Surg 51(6):322-326, 2003.
27. Rau BM, Frigerio I, Büchler MW, Wegscheider K, Bassi C, Puolakkainen PA, Beger HG, Schilling MK: Evaluation of procalcitonin for predicting septic multiorgan failure and overall prognosis in secondary peritonitis: a prospective, international multicenter study. Arch Surg 142(2):134-142, 2007.
28. Dahaba AA, Hagara B, Fall A, Rehak PH, List WF, Metzler H: Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis. Br J Anaesth 97(4):503-508, 2006.
29. Meisner M, Adina H, Schmidt J: Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients. Crit Care 10(1):R1, 2006.
30. Clec'h C, Fosse JP, Karoubi P, Vincent F, Chouahi I, Hamza L, Cupa M, Cohen Y: Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock. Crit Care Med 34(1):102-107, 2006.
31. Meisner M, Rauschmayer C, Schmidt J, Feyrer R, Cesnjevar R, Bredle D, Tschaikowsky K: Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complications. Intensive Care Med 28(8): 1094-1102, 2002.
32. Prieto B, Llorente E, González-Pinto I, Alvarez FV: Plasma procalcitonin measured by time-resolved amplified cryptate emission (TRACE) in liver transplant patients. A prognosis marker of early infectious and non-infectious postoperative complications. Clin Chem Lab Med 46(5):660-666, 2008.
33. Mokart D, Merlin M, Sannini A, Brun JP, Delpero JR, Houvenaeghel G, Moutardier V, Blache JL: Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. Br J Anaesth 94(6):767-773, 2005.